Published May 1st, 2026:
https://www.sciencedirect.com/science/article...1926000190
Highlights:
-A 40-year-old female patient was diagnosed with triple negative breast cancer
-Despite standard treatment she rapidly progressed with lung and liver metastases
-The patient subsequently received third-line atezolizumab plus leronlimab
-Following leronlimab PD-L1 expression on CTCs and CAMLs increased significantly
-She remains alive with no evidence of disease >60 months after starting leronlimab
________________________
I remain... #BULLISH
#CYDY #CCR5 #LERONLIMAB #DRJAY #DRKASI #DRPESTELL #OPENWATERS #OPENLABEL #ctDNA #CRC #COLDTOHOT #ALZ #mTNBC #MAKINGWAVES #OUTERLIMITS